Nano-Improvements to Rheumatoid Arthritis Stem Cell Therapy Show Success RA, which is marked by progressive joint degeneration and synovial inflammation, is one of the primary widespread inflammatory arthritis that affects around 1 % of the global population, however, it currently lacks an effective treatment. Read more...
New Strategy Reduces Brain Damage in Alzheimer’s and Related Disorders, in Mice Alzheimer’s disease is the most common and best known of the tauopathies, a set of neurodegenerative brain diseases caused by toxic tangles of the protein tau. A study by researchers at Washington University School of Medicine in St.
A Virtual Way to Rehab from a Stroke After a stroke, patients may lose feeling in an arm or experience weakness and reduced movement that limits their ability to complete basic daily activities. Traditional rehabilitation therapy is very intensive, time-consuming and can be both expensive and inconvenient, especially for rural
Novel Treatment Makes Pancreatic Cancer Susceptible to Immunotherapy, Mouse Study Shows Pancreatic cancer is one of the most aggressive and deadly tumor types and notorious for its resistance to virtually all types of treatment, including newer immunotherapies. Read more...
Can Music Improve Memory in Older Adults? Both the U.S. and the global population are aging, with the average age increasing from 21.5 in 1970 to over 30 in 2019. With this steady growth, the need to better understand age-associated diseases and pathologies grows as well. One aspect of mental
Koyal Garg, Ph.D. Koyal Garg, Ph.D., is an associate professor of Biomedical Engineering at Saint Louis University. Dr. Garg’s research focuses on the enhancement of skeletal muscle regeneration and function following injury, disease, and aging, --specifically focused on traumatic muscle injuries. In addition to her research, Dr.
Dr. Tolu Oyetunji Meet Dr. Tolu Oyetunji, Associate Professor of Pediatric Surgery at the University of Missouri-Kansas City (UMKC) School of Medicine and pediatric surgeon and the Director of Health Outcomes Research at the Children’s Mercy Kansas City (CMKC). As an academic pediatric surgeon, Dr. Oyentunji combines
FDA Approves Second CAR-T Cancer Therapy to Treat Multiple Myeloma, Opening the Door for Greater Access The Food and Drug Administration on Monday approved a new CAR-T therapy for multiple myeloma, a move that could ease strain on limited supplies of potentially lifesaving cancer therapies. Read more...
Intellia Now Has the Data for No. 1 Unanswered Gene Editing Question: Does It Last? Intellia Therapeutics proved last year that gene editing can work in humans. But a lingering question was, for how long? Now, the biotech has the data to begin to answer that question. Read more...
First Gene Therapy for Tay-Sachs Disease Successfully Given to Two Children Two babies have received the first-ever gene therapy for Tay-Sachs disease after over 14 years of development. Tay-Sachs is a severe neurological disease caused by a deficiency in an enzyme called HexA. This enzyme breaks down a fatlike substance
